Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and management

@article{Oconnor1999ReviewAH,
  title={Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and management},
  author={O’connor},
  journal={Alimentary Pharmacology \& Therapeutics},
  year={1999},
  volume={13}
}
  • O’connor
  • Published 1999
  • Medicine
  • Alimentary Pharmacology & Therapeutics
A significant proportion of patients with gastro‐oesophageal reflux disease (GERD) have Helicobacter pylori infection, but it is unclear whether or not H. pylori should be treated in this clinical setting. The aim of this review was to critically assess the relationship between H. pylori and GERD and its potential implications for the management of GERD. Data for this review were gathered from the following sources up to April 1998—the biomedical database M EDLINE, a detailed review of medical… Expand
Review article: the clinical influence of Helicobacter pylori in effective acid suppression—implications for the treatment of gastro‐oesophageal reflux disease
The relationship between gastro‐oesophageal reflux disease (GERD) and Helicobacter pylori is unclear. Recent data indicate that H. pylori probably exerts a protective effect against GERD. In recentExpand
Gastro‐oesophageal reflux disease and Helicobacter pylori infection
TLDR
The results of some studies suggest that eradication of H.’pylori may increase the risk for developing GERD, and some experts have suggested that chronic H. pylori infection may be of benefit. Expand
The Intriguing Relationship of Helicobacter Pylori Infection and Gastro-Oesophageal Reflux Disease
TLDR
There are more reasons that favour Helicobacter pylori eradication than to leave the bug in the stomach of patients, and the risk of gastric carcinogenesis and peptic ulcer formation against the need for possible higher doses of acid suppressive therapy after eradication should be balanced carefully. Expand
Helicobacter pylori and clinical risks—focus on gastro‐oesophageal reflux disease
TLDR
Research suggests that H. pylori may even confer protection against gastroesophageal reflux disease, and in a large proportion of the human population, the infection has no apparent adverse clinical consequences. Expand
[Helicobacter pylori and gastroesophageal reflux disease].
TLDR
H.p.p.) infection, particularly by cagA-positive strains, protects against the development of gastroesophageal reflux disease (GERD) and its complications and it is prudent to reserve H. p. Expand
Gastro-oesophageal reflux and Helicobacter pylori.
  • F. Pace, G. Bianchi porro
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2000
TLDR
It is now sufficiently clear that patients placed on long-term PPI therapy develop atrophic gastritis only if Helicobacter pylori infection is not eradicated, and the bacterial production of ammonia is the most likely factor explaining this observation. Expand
Helicobacter pylori eradication leads to gastro-oesophageal reflux disease
TLDR
A number of reports have claimed that H. pylori infection protects from gastro-oesophageal reflux disease (GORD), and that eradicating the infection may provoke GORD2. Expand
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
TLDR
Eradication of H. pylori infection appears advisable in patients on long-term proton pump inhibitors and an increase of inflammatory activity in fundic and corpus mucosa is a consistent phenomenon, in the authors' opinion. Expand
Treatment of Helicobacter pylori.
  • A. Harris
  • Medicine
  • World journal of gastroenterology
  • 2001
TLDR
The current treatment of Helicobacter pylori infection in patients with peptic ulcer disease, functional (non-ulcer) Dyspepsia or gastro-oesophageal reflux disease (GORD) is discussed and the potential role of eradication of H.pylori in preventing gastric cancer is addressed. Expand
The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia
TLDR
The cardia is an area where both H pylori and abnormal GERD exert their damaging potential, inducing inflammation and its consequences, such as intestinal metaplasia, and more studies are required to shed light on this issue to identify those patients that need surveillance. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 137 REFERENCES
Reflux oesophagitis and Helicobacter pylori infection in elderly patients.
TLDR
It is found that the high prevalence of H pylori in patients with reflux oesophagitis can be explained by the presence of incidental gastritis. Expand
Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor?
TLDR
The aim was to explore the strength of the postulate that H pylori is a causal factor in GORD by reviewing publications on epidemiological studies, clinical observations or treatment trials, and identifying possible pathogenic mechanisms. Expand
Helicobacter pylori and gastro-oesophageal reflux disease — A prospective study
TLDR
The results do not support the presence of a significant association between H. pylori infection and GORD. Expand
Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus.
TLDR
H pylori is not more common and its distribution does not differ in those with oesophagitis compared with control subjects, and is therefore unlikely to be aetiologically important in these patients. Expand
Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus.
TLDR
H. pylori probably has no etiologic role of esophagitis in Barrett's mucosa and is likely to show a low bacterial load in the metaplastic epithelium, which reflects a shift in the bacterium from the gastric antrum. Expand
Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection.
TLDR
The prevalence of cardia inflammation is similar in patients with and without GERD and is associated with H. pylori infection (P < 0.001) and intestinal metaplasia elsewhere in the stomach, indicating that it is distinct from Barrett's esophagus. Expand
Helicobacter pylori in Barrett's oesophagus
TLDR
H. pylori was observed in 31 biopsies of the 70 studied, mainly when the epithelium is of the gastric atrophic-fundic type, and does not seem to play an important role in the pathogenesis of the lesion. Expand
Esophagitis and Helicobacter pylori in children: incidence and therapeutic implications.
TLDR
Primary treatment of biopsy-confirmed esophagitis in children should include anti-secretory agents, regardless of H. pylori status, suggesting that presence of the organism should be assessed in all pediatric patients undergoing upper endoscopic evaluation. Expand
Critical issues in the management of gastroesophageal reflux disease.
TLDR
The superior clinical efficacy of PPIs when compared with any other drug regimen for GERD make them the treatment of choice for the short- and long-term management of this troublesome condition. Expand
Campylobacter Pylori and Reflux Oesophagitis
TLDR
It is concluded that Carnpylobucter pylori is unlikely to have a pathogenic role in reflux oesophagitis in children. Expand
...
1
2
3
4
5
...